Latest Earnings Outlook News

Page 3 of 18
McKesson delivered a strong fiscal second quarter, with revenue up 8% and adjusted diluted EPS rising 18%. The healthcare distributor lifted its full-year adjusted EPS guidance while expanding its specialty-care portfolio through new investments and acquisitions.
Ada Torres
Ada Torres
5 Nov 2026
Cencora delivered a stronger fiscal 2026, with adjusted earnings per share rising 12.3% and quarterly profit benefiting from the OneOncology acquisition. The healthcare distributor expects another 8% to 10% increase in adjusted EPS in fiscal 2027, while reshaping its reporting structure and lifting its dividend.
Ada Torres
Ada Torres
4 Nov 2026
Zimmer Biomet lifted its full-year 2026 sales and adjusted earnings guidance after third-quarter constant-currency growth accelerated to 3.7%. The result was supported by strong hips, sports medicine and technology sales, although GAAP earnings fell and knees remained a weak spot.
Ada Torres
Ada Torres
4 Nov 2026
Estée Lauder has set a fiscal 2030 ambition of mid-single-digit organic sales growth, an adjusted operating margin of 16.5% to 18.5%, and double-digit adjusted EPS growth. The company also raised its fiscal 2027 outlook after a strong first quarter, while flagging the execution and adjustment risks behind its long-range targets.
Victor Sage
Victor Sage
4 Nov 2026
Assurant lifted its 2026 earnings outlook after reporting strong third-quarter growth across its Lifestyle and Housing businesses. The insurer also plans to increase share repurchases to US$350 million, although catastrophe losses and reserve development remain important variables.
Victor Sage
Victor Sage
4 Nov 2026
AMETEK has lifted its full-year adjusted earnings guidance after delivering record third-quarter sales, earnings and cash flow. The industrial technology group also completed its Indicor Instrumentation acquisition during the quarter.
Maxwell Dee
Maxwell Dee
4 Nov 2026
Waters delivered a stronger-than-expected third quarter, lifting every component of its 2026 guidance while organic growth accelerated across instruments, consumables and reagents. The company also acquired MOBILion Systems to extend its mass spectrometry technology into proteomics.
Sophie Babbage
Sophie Babbage
4 Nov 2026
ADM delivered a sharp year-on-year increase in third-quarter earnings and raised its full-year adjusted EPS guidance, helped by stronger North American biofuels conditions. The company also cut its projected 2026 capital spending range, while warning that policy, trade and market factors remain fluid.
Victor Sage
Victor Sage
4 Nov 2026
Henry Schein has raised its 2026 adjusted earnings and EBITDA outlook after a quarter of stronger sales, led by US dental merchandise volumes. The result also included a tariff refund benefit, making the quality of earnings an important part of the story.
Ada Torres
Ada Torres
4 Nov 2026
New Zealand Rural Land Company’s 75%-owned partnership has made the $18.84 million sale of five Hawke’s Bay orchards unconditional. Settlement is expected within five working days, with net proceeds initially earmarked for bank debt repayment, although FY26 earnings guidance remains suspended.
Victor Sage
Victor Sage
3 Nov 2026
Healthpeak has raised its 2026 adjusted FFO and same-store NOI guidance after a quarter of strong senior housing growth, leasing activity and portfolio expansion. The uplift comes with a lower GAAP earnings outlook, reflecting depreciation from newly acquired senior housing assets.
Eva Park
Eva Park
3 Nov 2026
IDEXX Laboratories has raised its 2026 revenue and earnings outlook after reporting 10% third-quarter revenue growth and an 18% rise in diluted EPS. The upgrade came alongside rapid adoption of its inVue Dx analyzers, although acquisition costs prompted a lower full-year operating margin forecast.
Ada Torres
Ada Torres
2 Nov 2026

Browse the archive

Full archive